Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoring

Therapeutic Drug Monitoring

Volumn 22, Issue 2, 2000, Pages 160-162

  Morris, Raymond G ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cross reactivity; Cyclosporin; Immunoassay; Transplantation

Indexed keywords

CYCLOSPORIN;

AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; DIAGNOSTIC ACCURACY; DRUG CROSS REACTIVITY; DRUG DETERMINATION; DRUG METABOLISM; DRUG MONITORING; IMMUNOASSAY; PRIORITY JOURNAL;

CROSS REACTIONS; CYCLOSPORINE; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 0034071469     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200004000-00003     Document Type: Article

References (23)

1. Oellerich M, Armstrong VW, Kahan B, et al. Lake Louise consensus meeting on cyclosporin monitoring in organ transplantation: Report of the consensus panel. Ther Drug Monit 1995;17(6): 642-54.
2. Shaw LM, Yatscoff RW, Bowers LD, et al. Canadian consensus meeting on cyclosporine monitoring: report of the consensus panel. Clin Chem 1990;36(10):1841-6.
3. Sketris I, Yatscoff R, Keown P, et al. Optimizing the use of cyclosporine in renal transplantation. Clin Biochem 1995;28(3):195-211.
4. Kahan BD, Shaw LM, Holt D, Grevel J, Johnston A. Consensus Document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine. Clin Chem 1990;36(8):1510-6.
5. Shaw LM, Bowers L, Demers L, et al. Critical issues in cyclosporin monitoring: Report of the task force on cyclosporin monitoring. Clin Chem 1987;33(7):1269-88.
6. Morris RG, Tett SE, Ray JE. Cyclosporin-A monitoring in Australia: Consensus recommendations. Ther Drug Monit 1994;16(6): 570-6.
7. Morris RG. Australian cyclosporin therapeutic monitoring survey - 1993. Ther Drug Monit 1994;16(6):564-9.
8. Jones TE, Morris RG. Survey of cyclosporin therapeutic ranges, assay methodology and use of 'sparing agents' in Australasian transplant centres. Ther Drug Monit 1997;19:650-6.
9. Lindholm A, Kahan BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993;54:205-18.
10. Kahan BD, Welsh M, Rutzky LP. Challenges in cyclosporine therapy the role of therapeutic monitoring by area under the curve monitoring. Ther Drug Monit 1995;17(6):621-4.
11. Grevel J, Welsh MS, Kahan BD. Cyclosporin monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring. Ther Drug Monit 1989;11:252-66.
12. Amante AJ, Kahan BD. Abbreviated AUC strategy for monitoring cyclosporine microemulsion therapy in the immediate posttransplant period. Transplant Proc 1996;28(4):2162-3.
13. Marsh CL. Abbreviated pharmacokinetic profiles in area-under-the-curve monitoring of cyclosporin therapy in de novo renal transplant patients treated with Sandimmune or Neoral. Ther Drug Monit 1999;21:27-34.
14. Johnston A, Kovarik JM, Mueller, Holt DW. Predicting patients' exposure to cyclosporin. Transpl Int 1996;9(Suppl 1):S305-7.
15. Primmett DRN, Levine M, Kovarik JM, Mueller EA, Keown PA. Cyclosporine monitoring in patients with renal transplants: Two-or three-point methods that estimate area under the curve are superior to troughs in predicting drug exposure. Ther Drug Monit 1998;20:276-83.
16. Dusci LJ, Hackett LP, Chiswell GM, Ilett KF. Comparison of cyclosporine measurement in whole blood by high performance liquid chromatography, monoclonal fluorescence polarisation immunoassay and monoclonal enzyme multiplied immunoassay. Ther Drug Monit 1992;14:327-32.
17. Steimer W. Performance and specificity of monoclonal immunoassays for cyclosporin monitoring: How specific is specific? Clin Chem 1999;45(3):371-81.
18. Rogers LC, Smith PA. Evaluation of the Abbottt TDx monoclonal cyclosporine A assay in pediatric cardiac transplant patients. Clin Chem 1991;37(6):1014.
19. Morris RG, Saccoia NC, Ryall RG, Peacock MK, Sallustio BC. Specific EMIT and FPIA assays for cyclosporin compared with Cyclostrac 125I-RIA. Ther Drug Monit 1992;14(3):226-33.
20. Schutz E, Svinarov D, Shipkova M, et al. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and EMIT); a critical overview of performance characteristics and comparision with HPLC. Clin Chem 1998;44(10):2158-64.
21. Wallemacq PE, Alexandre K. Evaluatino of the new AxSYM cyclosporine assay: comparison with TDx monoclonal whole blood and EMIT cyclosporine assays. Clin Chem 1999;45(3):432-5.
22. Abbott AxSYM System - Cyclosporine [package insert]. Abbott-Laboratories; 1999;69-1770/R3:1-7.
23. Yatscoff RW, Copeland KR, Faraci CJ. Abbott TDx monoclonal assay evaluated for measuring cyclosporine in whole blood. Clin Chem 1990;36:1969-73.